Frequently Asked Questions
The Q-PCR and D-PCR devices market size will be worth USD 19.58 billion by 2031.
The growth rate of the Q-PCR and D-PCR devices market is 9.05% in the forecast period by 2031.
Technological advancements enhancing precision and efficiency & increasing prevalence of infectious diseases globally are the growth drivers of the Q-PCR and D-PCR devices market.
Technology, products and services, application and end user are the factors on which the Q-PCR and D-PCR devices market research is based.
Major companies in the Q-PCR and D-PCR devices market are F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc.(U.S.), Bio-Rad Laboratories, Inc.(U.S.), QIAGEN (Germany), Takara Bio Inc. (Japan), Agilent Technologies, Inc.(U.S.), bioMérieux SA (France), Danaher(U.S.), Abbott(U.S.), Merck KGaA (Germany), BD (U.S.), Promega Corporation(U.S.), Eppendorf AG (Germany), Analytik Jena GmbH (Germany), Meridian Bioscience, Inc.(U.S.), Enzo Life Sciences, Inc.(U.S.), Cole-Parmer Instrument Company, LLC.(U.S.), BIONEER CORPORATION (South Korea), ELITechGroup (France), Quantabio(U.S.).
